| 000 | 01873 a2200589 4500 | ||
|---|---|---|---|
| 005 | 20250517133543.0 | ||
| 264 | 0 | _c20171116 | |
| 008 | 201711s 0 0 eng d | ||
| 022 | _a1468-3296 | ||
| 024 | 7 |
_a10.1136/thoraxjnl-2016-208571 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHamid, U | |
| 245 | 0 | 0 |
_aAspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS. _h[electronic resource] |
| 260 |
_bThorax _c11 2017 |
||
| 300 |
_a971-980 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use |
| 650 | 0 | 4 |
_aAspirin _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers _xmetabolism |
| 650 | 0 | 4 | _aBronchoalveolar Lavage |
| 650 | 0 | 4 |
_aC-Reactive Protein _ximmunology |
| 650 | 0 | 4 |
_aCytokines _ximmunology |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation _xdrug therapy |
| 650 | 0 | 4 | _aInhalation |
| 650 | 0 | 4 |
_aInterleukin-8 _ximmunology |
| 650 | 0 | 4 |
_aLipopolysaccharides _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeutrophils _ximmunology |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRespiratory Distress Syndrome _xdiagnosis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aVolunteers |
| 700 | 1 | _aKrasnodembskaya, A | |
| 700 | 1 | _aFitzgerald, M | |
| 700 | 1 | _aShyamsundar, M | |
| 700 | 1 | _aKissenpfennig, A | |
| 700 | 1 | _aScott, C | |
| 700 | 1 | _aLefrancais, E | |
| 700 | 1 | _aLooney, M R | |
| 700 | 1 | _aVerghis, R | |
| 700 | 1 | _aScott, J | |
| 700 | 1 | _aSimpson, A J | |
| 700 | 1 | _aMcNamee, J | |
| 700 | 1 | _aMcAuley, D F | |
| 700 | 1 | _aO'Kane, C M | |
| 773 | 0 |
_tThorax _gvol. 72 _gno. 11 _gp. 971-980 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/thoraxjnl-2016-208571 _zAvailable from publisher's website |
| 999 |
_c26779643 _d26779643 |
||